-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Otsuka Holdings Co., Ltd. - Zipalertinib Plus Chemotherapy Meets Primary Pfs Endpoint In Planned Interim Analysis Of Phase 3 Rezilient3 Trial

路透·08/12/2026 23:32:06

登录查看新闻详情